Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Point8 Capital is a venture capital firm based in the United States, specializing in biotechnology investments. The firm is dedicated to supporting companies led by founders who are physicians or scientists, emphasizing clinically meaningful advancements in human therapeutics. Point8 focuses on companies that are ready for clinical trials, particularly those in Phase 2 or Phase 3.
Point8 Capital invests in biotechnology companies that are prepared for clinical trials, specifically targeting those in Phase 2 or Phase 3. The firm emphasizes founder-led governance and scientific rigor, engaging deeply in clinical planning and regulatory positioning to ensure a clear pathway to clinical inflection.
Point8 typically leads investment rounds in the biotechnology sector, particularly in Series A, B, and C stages.
The firm is open to follow-on investments, especially for companies that demonstrate significant clinical progress and alignment with their investment thesis.
Point8 distinguishes itself by focusing exclusively on companies led by scientific founders and engaging as scientific collaborators, providing both financial and strategic support.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.